Cargando…
Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells
Nasopharyngeal carcinoma (NPC) is a type of cancer originating in the nasopharynx. There are no NPC-specific treatments available at present. Serpin peptidase inhibitor clade C member 1 (SERPINC1) serves roles in anticoagulation and anti-inflammation. The aim of the present study was to investigate...
Autores principales: | Xu, Jin, Ying, Yin, Xiong, Gaoyun, Lai, Liqin, Wang, Qingliang, Yang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471593/ https://www.ncbi.nlm.nih.gov/pubmed/30896875 http://dx.doi.org/10.3892/mmr.2019.10021 |
Ejemplares similares
-
Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014) -
Amyloid β precursor protein silencing attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway
por: Xu, Jin, et al.
Publicado: (2019) -
High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma
por: Dokuni, Ryota, et al.
Publicado: (2020) -
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017) -
Serpin peptidase inhibitor clade A member 1-overexpression in gastric cancer promotes tumor progression in vitro and is associated with poor prognosis
por: Jiang, Longchang, et al.
Publicado: (2020)